Answers are grounded in this paper and cite their sources.
Overview examines efficacy of romosozumab and teriparatide in postmenopausal osteoporosis, suggesting further validation needed.
Romosozumab demonstrated efficacy and safety similar to teriparatide. However, this overview revealed substantial overlap among primary studies, with most outcomes assessed through indirect comparisons and poor methodological quality. Future research should confirm these findings.
No takes yet. Share an insight, caveat, or question.
Bandeira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: